fda rare disease database
How Fast Rare Disease Data Center Trumps Databases?
A biotech firm reduced data retrieval costs by 28% within six months after moving its genomic libraries to a rare disease data center. Centralizing rare disease data cuts expenses, speeds trials, and unlocks new revenue streams for biotech companies. The result: a faster path from bench to market. Medical Disclaimer: